Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

Saman Nematollahi, Shmuel Shoham

Research output: Contribution to journalReview article

Abstract

Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

Original languageEnglish (US)
JournalCurrent Fungal Infection Reports
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Scedosporium
Hyalin
Fusarium
Registries
Fungi
Randomized Controlled Trials
Clinical Trials
Infection
Therapeutics

Keywords

  • Antifungal therapy
  • Emerging fungal infections
  • Fusarium
  • Hyaline molds
  • Hyalohyphomycetes
  • Scedosporium

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections. / Nematollahi, Saman; Shoham, Shmuel.

In: Current Fungal Infection Reports, 01.01.2019.

Research output: Contribution to journalReview article

@article{b0e9524176bd42c5acac68ea9f4bf1b2,
title = "Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections",
abstract = "Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.",
keywords = "Antifungal therapy, Emerging fungal infections, Fusarium, Hyaline molds, Hyalohyphomycetes, Scedosporium",
author = "Saman Nematollahi and Shmuel Shoham",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12281-019-00364-4",
language = "English (US)",
journal = "Current Fungal Infection Reports",
issn = "1936-3761",
publisher = "Current Science, Inc.",

}

TY - JOUR

T1 - Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

AU - Nematollahi, Saman

AU - Shoham, Shmuel

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

AB - Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

KW - Antifungal therapy

KW - Emerging fungal infections

KW - Fusarium

KW - Hyaline molds

KW - Hyalohyphomycetes

KW - Scedosporium

UR - http://www.scopus.com/inward/record.url?scp=85076112705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076112705&partnerID=8YFLogxK

U2 - 10.1007/s12281-019-00364-4

DO - 10.1007/s12281-019-00364-4

M3 - Review article

AN - SCOPUS:85076112705

JO - Current Fungal Infection Reports

JF - Current Fungal Infection Reports

SN - 1936-3761

ER -